Dendritic Cell Vaccine and Cancer Treatment: New Patents
Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments
can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
Keywords: Cancer; dendritic cells; immunotherapy; neoplasia; new aspects; patents in immunotherapy; tumor
Document Type: Research Article
Publication date: 01 January 2014
- Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content